HiMEc – high-resolution spiral microfluidic channel integrated electrochemical device for isolation and detection of extracellular vesicles

Immunotherapy has emerged as a powerful tool, helping the body’s immune system target and destroy cancer cells. A key to making this therapy effective is identifying which patients are most likely to benefit from it. Recent research highlights the potential of extracellular vesicles (EVs)—tiny particles released by cells—as valuable indicators of how well immunotherapy might work. One exciting new development in this area is the high-resolution spiral microfluidic channel-integrated electrochemical device (HiMEc) developed at Yonsei University, a cutting-edge tool designed to improve how we detect these important immune markers on EVs.

What Is HiMEc?

HiMEc is a sophisticated device that uses a spiral microfluidic channel—a small, winding path through which liquid flows—to isolate and analyze EVs. These vesicles can carry crucial immune checkpoint markers, such as programmed death ligand 1 (PD-L1) and programmed death protein 1 (PD-1), which play a significant role in how tumors evade immune detection.

How Does HiMEc Work?

Here’s a simplified breakdown of HiMEc’s process:

  1. Separation of EVs from Other Particles: Blood plasma contains many types of particles, including lipoproteins (fat-carrying particles) and EVs. To focus on EVs, HiMEc uses beads coated with antibodies that capture lipoproteins, leaving behind the smaller EVs.
  2. Isolation and Detection: Plasma is introduced into the spiral microfluidic channel. The design allows the device to separate nanometer-sized EVs from the larger lipoprotein-bead complexes effectively. This means that HiMEc can isolate EVs carrying PD-L1 and PD-1 markers with high precision.
  3. Analysis: The device then measures the levels of these markers on EVs from plasma samples. In testing, HiMEc was used to analyze samples from both healthy individuals and lung cancer patients, showing how it can potentially help in assessing who might benefit from immunotherapy.

Why Is HiMEc Important?

The traditional method for evaluating PD-L1 and PD-1 levels usually involves analyzing tissue samples, which can be invasive and less efficient. HiMEc offers a non-invasive alternative by using blood plasma, making the process quicker and less uncomfortable for patients. It also provides high-resolution data that can help better match patients with the right immunotherapy treatments.

By improving our ability to detect and measure these critical markers, HiMEc could significantly enhance the clinical assessment of patients and help tailor treatments more precisely. This innovation represents a step forward in personalized medicine, aiming to ensure that the benefits of immunotherapy are maximized for those who need it most.

Kwon YH, Park S, Jiang H, Gurudatt NG, Lee K, Jeong H, Nie C, Shin , Hyun KA, Jung HI. (2024) High-resolution spiral microfluidic channel integrated electrochemical device for isolation and detection of extracellular vesicles without lipoprotein contamination. Biosensors and Bioelectronics [Epub ahead of print]. [article]

Leave a Reply

Your email address will not be published. Required fields are marked *

*